Skip to content
10-K

Annual Report

ALX ONCOLOGY HOLDINGS INC ALXO

0000950170-25-034761

← back to feed
Filed
Mar 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 27, 2025 53.38M sh
Long Term Debt FY 2024 · Dec 31, 2023 $9.64M
Short Term Investments FY 2024 · Dec 31, 2023 $160.33M
Current Liabilities FY 2024 · Dec 31, 2023 $36M
Total Liabilities FY 2024 · Dec 31, 2023 $52.84M
Current Assets FY 2024 · Dec 31, 2023 $188.66M
Total Assets FY 2024 · Dec 31, 2023 $242.55M
Shares Diluted FY 2024 · Dec 31, 2022 40.7M sh
Capex FY 2024 · Dec 31, 2022 $1.43M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$89.22M
Cash And Equivalents FY 2024 · Dec 31, 2022 $48.82M
Eps Diluted FY 2024 · Dec 31, 2022 −$3.03
Eps Basic FY 2024 · Dec 31, 2022 −$3.03
Sga Expense FY 2024 · Dec 31, 2022 $29.04M
Rd Expense FY 2024 · Dec 31, 2022 $98.4M
Net Income FY 2024 · Dec 31, 2022 −$123.48M
Operating Income FY 2024 · Dec 31, 2022 −$127.44M
Stockholders Equity FY 2024 · Dec 31, 2021 $363.05M